Add BrightSurf on Google Email

iPS cells used to correct genetic mutations that cause muscular dystrophy

Researchers used iPS cells to correct genetic mutations in Duchenne muscular dystrophy (DMD), a severe muscular degenerative disease. Engineered nucleases TALEN and CRISPR were successfully used to edit the genome of iPS cells generated from DMD patient skin cells, resulting in the disappearance of the mutation responsible for DMD.

Breakthrough made at Max F. Perutz Laboratories

Researchers at the Max F. Perutz Laboratories have developed a method for generating specific and inheritable mutations in the marine bristle worm Platynereis, enabling detailed in vivo functional analyses and advancing research in neurobiology, chronobiology, evolutionary developmental biology, and marine biology.

SourceUniversity of Vienna·JournalGenetics·DateMay 8, 2014

Fast track to mouse modeling

Scientists have developed a new method to create genetically modified mice that accelerates the process by four months, using TALEN enzymes. This technique allows for the efficient production of mouse models for diseases like dementia, reducing the need for numerous test animals.

SourceTechnical University of Munich (TUM)·JournalProceedings of the National Academy of Sciences·DateApr 2, 2013